Accepting applications until August 1

City of Hope Intensive Course in Genomic Cancer Risk Assessment

Accepting applications until August 1

G7 Leaders' Call on the Fight Against Cancer

OncoDaily. 2026 Jun 18

On June 17, 2026, the leaders of the G7—joined by Brazil, Egypt, India, Kenya, and the Republic of Korea—issued a joint call to accelerate the global fight against cancer, a disease that kills nearly 10 million people a year and w... Read More

Age-Based Screening for Lung Cancer Surveillance in the US

Hee Chul Yang, Austin Chang, Maxime Visa, et al. JAMA Netw Open. 2025 Nov 3;8(11):e2546222

Lung cancer is increasingly diagnosed in never-smokers, suggesting that the current US Preventive Services Task Force (USPSTF) screening criteria using low-dose computed tomography exclude many at-risk individuals, thus raising co... Read More

Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer

Zoulikha Rezoug , Stephanie P Totten, David Szlachtycz, et al. JAMA Netw Open. 2024 Sep 3;7(9):e2431427

Between 5% and 10% of breast cancer cases are associated with an inherited germline pathogenic or likely pathogenic variant (GPV) in a breast cancer susceptibility gene (BCSG), which could alter local and systemic therapy recommen... Read More

Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial

Kirkpatrick B Fergus, Katherine S Ross, Maren T Scheuner, et al. JAMA Intern Med. 2026 Mar 1;186(3):344-352

Among 23 098 women who completed germline genetic testing (mean age, 54.3 years), 714 (3.1%) carried a PV. Excluding 109 who were previously aware of their PV, the detection rate was 2.6%. PVs were most common in CHEK2 (337) and A... Read More